Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
IFT80 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM167A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HINT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDXDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VEZF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POGZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CACYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MURC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNIH4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on